Prevention of Invasive Pneumococcal Disease Among Black or African American Children With and Without Sickle Cell Disease in the United States After Introduction of 13‐Valent Pneumococcal Conjugate Vaccine, 2005 Through 2019

Documents similaires

• Clinical Features and Outcomes of Pneumococcal Bacteremia in Children With Sickle Cell Disease in the Pneumococcal Conjugate Vaccine Era
  par: Marianne E. Yee, et autres
  Publié: (2025)
• Medication Utilization Among Children With Sickle Cell Disease in the United States
  par: Abiodun John Ologunowa, et autres
  Publié: (2025)
• Meeting the Challenge: Prevention of Pneumococcal Disease with Conjugate Vaccines
  par: Irma Gabriela Echániz Avilés
  Publié: (2001)
• Optimizing Transcranial Doppler Screening for Stroke Prevention in Young African Children With Sickle Cell Disease
  par: Derby Tembo, et autres
  Publié: (2025)
• Pregnancy‐ and Disease‐Related Morbidity Among Medicaid Enrollees With Sickle Cell Disease
  par: Mariam Kayle, et autres
  Publié: (2025)